These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 2909858)

  • 1. Time to lower cholesterol.
    Cowling BD
    Med J Aust; 1989 Jan; 150(1):55. PubMed ID: 2909858
    [No Abstract]   [Full Text] [Related]  

  • 2. Detection and management of individuals and populations at risk for cardiovascular disease: Time to take a stance on cholesterol and lipoproteins. Winnipeg, Manitoba, September 14 and 15, 1987. Proceedings.
    Can J Cardiol; 1988 Jul; 4 Suppl A():1A-50A. PubMed ID: 3179798
    [No Abstract]   [Full Text] [Related]  

  • 3. [Nuanced view on cholesterol. New guidelines on prevention of cardiovascular diseases].
    Olsson AG
    Lakartidningen; 1993 Jul; 90(28-29):2525-7. PubMed ID: 8326795
    [No Abstract]   [Full Text] [Related]  

  • 4. [What does the reduction of cholesterol benefit?].
    Ugeskr Laeger; 1990 Feb; 152(8):546-52. PubMed ID: 2309367
    [No Abstract]   [Full Text] [Related]  

  • 5. Diet and cardiovascular disease: beyond cholesterol.
    Rivellese AA
    Nutr Metab Cardiovasc Dis; 2005 Dec; 15(6):395-8. PubMed ID: 16314224
    [No Abstract]   [Full Text] [Related]  

  • 6. [Karl Popper and the cholesterol hypothesis].
    Ravnskov U
    Tidsskr Nor Laegeforen; 2004 Oct; 124(19):2517. PubMed ID: 15477904
    [No Abstract]   [Full Text] [Related]  

  • 7. [Experience in primary prevention of cardiovascular risk factors in children].
    Rossi P; Rizzotti M; Rognoni G; Salvaneschi G
    G Ital Cardiol; 1994 Feb; 24(2):99-106. PubMed ID: 8013773
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Use of physiotherapeutic technology in correcting risk factors for cardiovascular diseases].
    Sorokina EI
    Vopr Kurortol Fizioter Lech Fiz Kult; 2000; (5):12-6. PubMed ID: 11247138
    [No Abstract]   [Full Text] [Related]  

  • 9. Lipid management to reduce cardiovascular risk: a new strategy is required.
    Superko HR; King S
    Circulation; 2008 Jan; 117(4):560-8; discussion 568. PubMed ID: 18227396
    [No Abstract]   [Full Text] [Related]  

  • 10. [High cholesterol level may protect against infections and probably also atherosclerosis].
    Ravnskov U
    Lakartidningen; 2004 Mar; 101(13):1215-7; discussion 1218, 1221-2. PubMed ID: 15101249
    [No Abstract]   [Full Text] [Related]  

  • 11. A supermarket cardiovascular screening program: analysis of participants' solicitation of follow-up care.
    Strychar IM; Potvin L; Pineault R; Pineau R; Prévost D
    Am J Prev Med; 1994; 10(5):283-9. PubMed ID: 7848671
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Public policy and dietary recommendations to reduce population levels of blood cholesterol.
    Blackburn H
    Am J Prev Med; 1985; 1(5):3-11. PubMed ID: 3870917
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Smoking combined with overweight or obesity markedly elevates cardiovascular risk factors.
    Akbartabartoori M; Lean ME; Hankey CR
    Eur J Cardiovasc Prev Rehabil; 2006 Dec; 13(6):938-46. PubMed ID: 17143126
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiovascular risk: who should we treat, and how much should we stratify?
    Patel A
    Heart; 2009 May; 95(10):783-4. PubMed ID: 19131441
    [No Abstract]   [Full Text] [Related]  

  • 15. [The family practitioner's dilemma: the total serum cholesterol between 5 and 8 mmol/l].
    Wahlberg G
    Lakartidningen; 2008 Oct 1-7; 105(40):2788-9. PubMed ID: 18953792
    [No Abstract]   [Full Text] [Related]  

  • 16. Statins and cardiovascular disease--major therapeutic advances but are we seizing the moment?
    Mulcahy D
    Eur Heart J; 2001 Jul; 22(13):1065-6. PubMed ID: 11428844
    [No Abstract]   [Full Text] [Related]  

  • 17. [Impact of consensus for control of cholesterolemia in Spain].
    Masana L; Pedro-Botet J; Ros E; Rubiés-Prat J
    Med Clin (Barc); 1998 May; 110(15):598-9. PubMed ID: 9650208
    [No Abstract]   [Full Text] [Related]  

  • 18. Cardiovascular health. Statin therapy reduces disease in healthy volunteers--but how, exactly?
    Couzin J
    Science; 2008 Nov; 322(5904):1039. PubMed ID: 19008423
    [No Abstract]   [Full Text] [Related]  

  • 19. Do hypertensive patients with average cholesterol levels benefit from atorvastatin therapy?
    Hackam DG
    CMAJ; 2003 Jun; 168(13):1689. PubMed ID: 12821623
    [No Abstract]   [Full Text] [Related]  

  • 20. Short-term effects of weight loss on the cardiovascular risk factors in morbidly obese patients.
    Busetto L; Sergi G; Enzi G; Segato G; De Marchi F; Foletto M; De Luca M; Pigozzo S; Favretti F
    Obes Res; 2004 Aug; 12(8):1256-63. PubMed ID: 15340108
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.